2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
22
Terminated
8
Recruiting
6
Active not recruiting
2
Unknown
1
Not yet recruiting
1
No longer available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
544
Neoplasms
384
Carcinoma, Non-Small-Cell Lung
325
Colorectal Neoplasms
296
Lung Neoplasms
237
Prostatic Neoplasms
220
Carcinoma, Hepatocellular
213
Stomach Neoplasms
155
Pancreatic Neoplasms
155
Leukemia, Myeloid, Acute
141
Uterine Cervical Neoplasms
132
Multiple Myeloma
130
Recurrence
120
Rectal Neoplasms
114
Ovarian Neoplasms
109
Neoplasm Metastasis
105
Squamous Cell Carcinoma of Head and Neck
98
Head and Neck Neoplasms
91
Triple Negative Breast Neoplasms
87
Esophageal Neoplasms
84
Glioblastoma
82
Endometrial Neoplasms
80
Small Cell Lung Carcinoma
79
Brain Neoplasms
79
Colonic Neoplasms
78
Melanoma
71
Precursor Cell Lymphoblastic Leukemia-Lymphoma
65
Hematologic Neoplasms
65
Glioma
63
Disease
60
Interventions
Quality of Life
1
Electrocardiography
1
Clinical Laboratory Techniques
1
Bone Marrow Examination
1
Azacitidine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Bone Marrow Diseases
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled